Related Experiment Video
Updated: Apr 15, 2026
05:23
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
903
Helicobacter pylori eradication in gastric diffuse large B cell lymphoma
1Semra Paydas, Department of Oncology, Cukurova University Faculty of Medicine 01330 Balcali, Turkey.
World Journal of Gastroenterology
|April 9, 2015
Summary
Helicobacter pylori (H. pylori) eradication effectively treats some gastric lymphomas, offering an alternative to chemotherapy. Careful histopathological follow-up is essential to guide treatment decisions for these H. pylori-dependent cases.
Area of Science:
- Oncology
- Gastroenterology
- Microbiology
Background:
- Gastric lymphomas are heterogeneous, including de novo diffuse large B cell lymphoma (DLBCL) and DLBCL associated with MALT lymphoma.
- Helicobacter pylori (H. pylori) eradication has long been linked to MALT lymphoma remission.
- Emerging evidence suggests H. pylori dependency in some high-grade gastric lymphomas.
Discussion:
- H. pylori-dependent gastric lymphomas represent a distinct biological entity with a better prognosis than H. pylori-negative cases.
- Antibiotic treatment for H. pylori eradication offers a less toxic alternative to chemotherapy for select patients.
- Strict histopathological evaluation using established scoring systems is crucial for monitoring treatment response.
Key Insights:
- H. pylori eradication is a viable and effective treatment strategy for H. pylori-dependent gastric lymphomas.
- Complete remission can be achieved in some cases with brief antibiotic courses, avoiding chemotherapy.
- H. pylori dependency and high-grade transformation in gastric MALT lymphomas are distinct pathological events.
Outlook:
- Further research into H. pylori's role in gastric lymphomagenesis may reveal novel therapeutic targets.
- Wider adoption of H. pylori eradication protocols for appropriate gastric lymphoma cases could improve patient outcomes.
- Continued refinement of diagnostic and monitoring tools will enhance personalized treatment strategies.
Related Concept Videos
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
2.3K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.3K
01:23Gastritis III: Clinical Manifestations and Management
1.8K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.8K
01:26Peptic Ulcer Disease IV: Management
690
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
690
01:27Peptic Ulcer
35
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
35
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
850
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
850